Literature DB >> 31347281

Increased pulmonary artery diameter is associated with reduced FEV1 in former World Trade Center workers.

Rafael E de la Hoz1,2, Yunho Jeon1, Anthony P Reeves3, Raúl San José Estépar4, Xiaoyu Liu5, John T Doucette1, Juan C Celedón6, Anna Nolan7.   

Abstract

RATIONALE: Occupational exposures at the WTC site after September 11, 2001 have been associated with several presumably inflammatory lower airway diseases. Pulmonary arterial enlargement, as suggested by an increased ratio of the diameter of the pulmonary artery to the diameter of the aorta (PAAr) has been reported as a computed tomographic (CT) scan marker of adverse respiratory health outcomes, including WTC-related disease. In this study, we sought to utilize a novel quantitative CT (QCT) measurement of PAAr to test the hypothesis that an increased ratio is associated with FEV1 below each subject's statistically determined lower limit of normal (FEV1  < LLN).
METHODS: In a group of 1,180 WTC workers and volunteers, we examined whether FEV1  < LLN was associated with an increased QCT-measured PAAr, adjusting for previously identified important covariates.
RESULTS: Unadjusted analyses showed a statistically significant association of FEV1  < LLN with PAAr (35.3% vs 24.7%, P = 0.0001), as well as with height, body mass index, early arrival at the WTC disaster site, shorter WTC exposure duration, post-traumatic stress disorder checklist (PCL) score, wall area percent and evidence of bronchodilator response. The multivariate logistic regression model confirmed the association of FEV1  < LLN with PAAr (OR 1.63, 95% CI 1.21, 2.20, P = 0.0015) and all the unadjusted associations, except for PCL score.
CONCLUSIONS: In WTC workers, FEV1  < LLN is associated with elevated PAAr which, although likely multifactorial, may be related to distal vasculopathy, as has been hypothesized for chronic obstructive pulmonary disease.
© 2019 John Wiley & Sons Ltd.

Entities:  

Keywords:  2001; World Trade Center attack; computer-assisted image processing; multidetector computed tomography; occupational medicine; pulmonary artery; smoke inhalation injury; spirometry

Mesh:

Substances:

Year:  2019        PMID: 31347281      PMCID: PMC6783324          DOI: 10.1111/crj.13067

Source DB:  PubMed          Journal:  Clin Respir J        ISSN: 1752-6981            Impact factor:   2.570


  42 in total

1.  The clinical diagnosis of pulmonary emphysema; an experimental study.

Authors:  C M FLETCHER
Journal:  Proc R Soc Med       Date:  1952-09

2.  Irritant-induced occupational asthma.

Authors:  S M Tarlo; I Broder
Journal:  Chest       Date:  1989-08       Impact factor: 9.410

3.  Air trapping detected on end-expiratory high-resolution computed tomography in symptomatic World Trade Center rescue and recovery workers.

Authors:  David S Mendelson; Mark Roggeveen; Stephen M Levin; Robin Herbert; Rafael E de la Hoz
Journal:  J Occup Environ Med       Date:  2007-08       Impact factor: 2.162

4.  Three-dimensional airway measurements and algorithms.

Authors:  Raúl San José Estépar; John J Reilly; Edwin K Silverman; George R Washko
Journal:  Proc Am Thorac Soc       Date:  2008-12-15

5.  Work-related asthma in Montreal, Quebec: population attributable risk in a community-based study.

Authors:  Ahmet Demir; Lawrence Joseph; Margaret R Becklake
Journal:  Can Respir J       Date:  2008 Nov-Dec       Impact factor: 2.409

6.  Health care and social issues of immigrant rescue and recovery workers at the World Trade Center site.

Authors:  Rafael E de la Hoz; Scottie Hill; Rachel Chasan; Laura A Bienenfeld; Aboaba A Afilaka; Elizabeth Wilk-Rivard; Robin Herbert
Journal:  J Occup Environ Med       Date:  2008-12       Impact factor: 2.162

7.  Occupational toxicant inhalation injury: the World Trade Center (WTC) experience.

Authors:  Rafael E de la Hoz; Michael R Shohet; Rachel Chasan; Laura A Bienenfeld; Aboaba A Afilaka; Stephen M Levin; Robin Herbert
Journal:  Int Arch Occup Environ Health       Date:  2007-09-05       Impact factor: 3.015

8.  Occupational asthma and lower airway disease among World Trade Center workers and volunteers.

Authors:  Rafael E de la Hoz
Journal:  Curr Allergy Asthma Rep       Date:  2010-07       Impact factor: 4.806

9.  Pulmonary arterial enlargement and acute exacerbations of COPD.

Authors:  J Michael Wells; George R Washko; MeiLan K Han; Naseer Abbas; Hrudaya Nath; A James Mamary; Elizabeth Regan; William C Bailey; Fernando J Martinez; Elizabeth Westfall; Terri H Beaty; Douglas Curran-Everett; Jeffrey L Curtis; John E Hokanson; David A Lynch; Barry J Make; James D Crapo; Edwin K Silverman; Russell P Bowler; Mark T Dransfield
Journal:  N Engl J Med       Date:  2012-09-03       Impact factor: 91.245

10.  Metabolic syndrome biomarkers predict lung function impairment: a nested case-control study.

Authors:  Bushra Naveed; Michael D Weiden; Sophia Kwon; Edward J Gracely; Ashley L Comfort; Natalia Ferrier; Kusali J Kasturiarachchi; Hillel W Cohen; Thomas K Aldrich; William N Rom; Kerry Kelly; David J Prezant; Anna Nolan
Journal:  Am J Respir Crit Care Med       Date:  2011-11-17       Impact factor: 21.405

View more
  3 in total

Review 1.  Health effects following exposure to dust from the World Trade Center disaster: An update.

Authors:  Matthew J Mears; David M Aslaner; Chad T Barson; Mitchell D Cohen; Matthew W Gorr; Loren E Wold
Journal:  Life Sci       Date:  2021-11-14       Impact factor: 5.037

2.  Quantitative CT Evidence of Airway Inflammation in WTC Workers and Volunteers with Low FVC Spirometric Pattern.

Authors:  Jonathan Weber; Anthony P Reeves; John T Doucette; Yunho Jeon; Akshay Sood; Raúl San José Estépar; Juan C Celedón; Rafael E de la Hoz
Journal:  Lung       Date:  2020-04-01       Impact factor: 2.584

3.  Dynamic Metabolic Risk Profiling of World Trade Center Lung Disease: A Longitudinal Cohort Study.

Authors:  Sophia Kwon; Myeonggyun Lee; George Crowley; Theresa Schwartz; Rachel Zeig-Owens; David J Prezant; Mengling Liu; Anna Nolan
Journal:  Am J Respir Crit Care Med       Date:  2021-11-01       Impact factor: 21.405

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.